Literature DB >> 15059032

Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.

Belén Roldán1, José L San Millán, Héctor F Escobar-Morreale.   

Abstract

Polycystic ovary syndrome (PCOS) is a common heterogeneous disorder characterized by hyperandrogenism and chronic anovulation. The syndrome is frequently associated with an increased risk for insulin resistance and type 2 diabetes mellitus; obesity exacerbates insulin resistance and favors the progression from impaired glucose tolerance to diabetes in these patients. In young women, precocious pubarche and hyperinsulinemia are early manifestations of PCOS. The familial clustering of women with PCOS suggests that heredity is implicated in the origin of the syndrome. However, genetic approaches to its pathogenesis have been hampered by the heterogeneity of phenotypic features within families, and the lack of uniform criteria for diagnosis. Currently, PCOS is considered a polygenic trait that might result from the interaction of susceptibility and protective genomic variants under the influence of environmental factors. Both linkage analysis and association studies are valid tools for the study of the genetics of PCOS. Candidate genes for PCOS include those related to androgenic pathways and metabolic associations of the syndrome. More recently, genes encoding inflammatory cytokines have been identified as target genes for PCOS, as proinflammatory genotypes and phenotypes are also associated with obesity, insulin resistance, type 2 diabetes, PCOS, and increased cardiovascular risk. This paper reviews the candidate genes involved in the metabolic pathways that are altered in patients with PCOS. Despite a significant amount of research in this area, none of the genes studied so far has been identified as the PCOS susceptibility gene for the majority of cases. PCOS is the first component of the metabolic syndrome to be detected in many women, so the identification and correct diagnosis of PCOS has important preventive and therapeutic implications for the affected women and their families. In the future, new therapeutic approaches to PCOS will rely on knowing the genes, environmental influences, and etiologic mechanisms associated with the disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15059032     DOI: 10.2165/00129785-200404020-00004

Source DB:  PubMed          Journal:  Am J Pharmacogenomics        ISSN: 1175-2203


  5 in total

1.  Evaluation of the Prevalence, Regional Phenotypic Variation, Comorbidities, Risk Factors, and Variations in Response to Different Therapeutic Modalities Among Indian Women: Proposal for the Indian Council of Medical Research-Polycystic Ovary Syndrome (ICMR-PCOS) Study.

Authors:  Mohd Ashraf Ganie; Subhankar Chowdhury; Vanita Suri; Beena Joshi; Prasanta Kumar Bhattacharya; Sarita Agrawal; Neena Malhotra; Rakesh Sahay; Roya Rozati; Puthiyaveettil Khadar Jabbar; Vishnubhatla Sreenivas; Mukesh Sriwastva; Imtiyaz Ahmad Wani; Shalini Singh; Radhey Shyam Sharma
Journal:  JMIR Res Protoc       Date:  2021-08-27

2.  Common polymorphisms of calpain-10 and the risk of polycystic ovary syndrome in Tunisian population: a case-control study.

Authors:  Assila Ben Salem; Redha Attaoua; Nabil Mtiraoui; Sana Belkahla; Intissar Ezzidi; Mounir Ajina; Moncef Souissi; Patrick Poucheret; Madalina Vintila; Florin Grigorescu; Touhami Mahjoub
Journal:  Mol Biol Rep       Date:  2014-07-04       Impact factor: 2.316

Review 3.  Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.

Authors:  Zahra Shaaban; Arezoo Khoradmehr; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

4.  Association of follistatin and cytochrome p450 side-chain cleavage enzyme with polycystic ovarian syndrome.

Authors:  Fouzia Nazir; S Inayatullah; S Jalali
Journal:  Int J Health Sci (Qassim)       Date:  2022 Sep-Oct

Review 5.  Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome.

Authors:  Zahra Shaaban; Arezoo Khoradmehr; Amir Amiri-Yekta; Fariborz Nowzari; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Genet Res (Camb)       Date:  2021-12-06       Impact factor: 1.588

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.